Fig. 7From: Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological informationOverlay of FDA’s TPLC approach based on GMLP and artificial intelligence/machine learning modified workflow [196]. This TPLC approach can enable the organization to continuously excel by evaluating and monitoring software products from development to post-sale performanceBack to article page